Caris Downgrades Endo Pharmaceuticals (ENDP) to Average, Raises Price Target

December 13, 2010 8:51 AM EST Send to a Friend
Get Alerts ENDP Hot Sheet
Price: $73.17 +1.05%

Rating Summary:
    18 Buy, 12 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 3 | Down: 17 | New: 2
Trade ENDP Now!
Join SI Premium – FREE
Caris & Co. downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) to an Average rating from its previous rating of Above Average. They are also raising their price target to $38 from from $28.

For more ratings news on Endo Pharmaceuticals Holdings Inc click here and for the rating history of Endo Pharmaceuticals Holdings Inc click here.

Shares of Endo Pharmaceuticals Holdings Inc closed at $36.46 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Add Your Comment